Pub Date : 2025-12-02DOI: 10.1080/1354750X.2025.2596012
Hui Yuan, Qian Wu, Nan Yu, Tang Zhang
Background: Biomarkers for CTD-ILD diagnosis, treatment response evaluation, and pathogenesis elucidation are lacking. Licorice-dried ginger soup alleviates lung injury, but its mechanism is unknown. This study aimed to identify biomarkers of this herbal treatment for CTD-ILD.
Methods: Public datasets of Peripheral blood mononuclear cells (PBMCs) from CTD-ILD (n = 4) and connective tissue disease-associated non-Inflammatory lung disease (CTD-NILD) (n = 3) patients were analyzed using differential expression (p.adj < 0.05 & |log2 Fold Change (FC)| > 0.5), protein-protein interaction networks, and cytohubba algorithms (Top5 genes from six algorithms). Functional enrichment, upstream pathway activity, phosphorylation, molecular regulatory networks, and molecular docking were performed and the expression of biomarkers was validated in clinical samples.
Results: Five biomarkers (CXCL8, IL1A, IL1B, NFE2L2, and PTGS2) were identified. Functional analysis linked these pathways to innate immunity, cytokine activity, and pertussis pathways. Regulatory networks have been implicated in toll-like receptors, chemokine signaling, and DNA replication. Biomarkers correlated with lung injury and showed high expression in the blood/immune cells. Molecular docking confirmed strong binding between the biomarkers and quercetin.
Conclusion: CXCL8, IL1A, IL1B, NFE2L2, and PTGS2 are critical CTD-ILD biomarkers. Licorice ginger soup may target these genes via quercetin, providing novel diagnostic and therapeutic insights.
{"title":"Bioinformatics-based screening and experimental validation of biomarkers for the treatment of connective tissue-associated interstitial lung disease with liquorice and dried ginger soup.","authors":"Hui Yuan, Qian Wu, Nan Yu, Tang Zhang","doi":"10.1080/1354750X.2025.2596012","DOIUrl":"https://doi.org/10.1080/1354750X.2025.2596012","url":null,"abstract":"<p><strong>Background: </strong>Biomarkers for CTD-ILD diagnosis, treatment response evaluation, and pathogenesis elucidation are lacking. Licorice-dried ginger soup alleviates lung injury, but its mechanism is unknown. This study aimed to identify biomarkers of this herbal treatment for CTD-ILD.</p><p><strong>Methods: </strong>Public datasets of Peripheral blood mononuclear cells (PBMCs) from CTD-ILD (n = 4) and connective tissue disease-associated non-Inflammatory lung disease (CTD-NILD) (n = 3) patients were analyzed using differential expression (p.adj < 0.05 & |log2 Fold Change (FC)| > 0.5), protein-protein interaction networks, and cytohubba algorithms (Top5 genes from six algorithms). Functional enrichment, upstream pathway activity, phosphorylation, molecular regulatory networks, and molecular docking were performed and the expression of biomarkers was validated in clinical samples.</p><p><strong>Results: </strong>Five biomarkers (CXCL8, IL1A, IL1B, NFE2L2, and PTGS2) were identified. Functional analysis linked these pathways to innate immunity, cytokine activity, and pertussis pathways. Regulatory networks have been implicated in toll-like receptors, chemokine signaling, and DNA replication. Biomarkers correlated with lung injury and showed high expression in the blood/immune cells. Molecular docking confirmed strong binding between the biomarkers and quercetin.</p><p><strong>Conclusion: </strong>CXCL8, IL1A, IL1B, NFE2L2, and PTGS2 are critical CTD-ILD biomarkers. Licorice ginger soup may target these genes via quercetin, providing novel diagnostic and therapeutic insights.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"1-26"},"PeriodicalIF":1.9,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Base excision repair (BER) plays a vital role in repairing DNA damage; however, polymorphisms in BER genes may influence an individual's susceptibility to disease risk. We investigated the role of BER genes as a biomarker of susceptibility among agricultural workers in Haryana, India.
Methods: The pesticide-exposed workers (110) and unexposed controls (114) were genotyped for XRCC1 C26304T (rs1799782), XRCC1 G28152A (rs25487), APE1 T2197G (rs1130409), and OGG1 C1245G (rs1052133) using the PCR-RFLP technique. The allelic frequencies were compared using chi-square tests, with a significance level set at p < 0.05.
Results: Significant results were observed for XRCC1: rs1799782 (T allele: 0.1409 vs. 0.0658; OR: 2.32; CI: 1.08-4.99; p: 0.028) and rs25487 (A allele: 0.332 vs. 0.202; OR: 1.90; CI: 1.29-2.80; p: 0.001) between exposed and control groups. The frequency of the APE1 Glu allele was significantly lower in exposed individuals (OR: 0.49; CI: 0.31-0.78; p = 0.003). In contrast, the OGG1 Cys allele was more frequent in the exposed group; however, the difference was not statistically significant (OR: 1.43; CI: 0.91-2.23; p = 0.113).
Conclusion: Our findings suggest that DNA repair gene polymorphism may influence an individual's susceptibility to pesticide exposure, leading to oxidative damage and genotoxic effects.
{"title":"Impact of pesticide exposure on base excision repair gene polymorphisms in the Haryana population.","authors":"Heena Gulia, Jagphool Singh, Soniya Jangra, Amita Suneja Dang, Gulab Singh, Shiv Kumar Giri, Neha Verma, Kanu Priya, Anil Kumar","doi":"10.1080/1354750X.2025.2591715","DOIUrl":"10.1080/1354750X.2025.2591715","url":null,"abstract":"<p><strong>Objective: </strong>Base excision repair (BER) plays a vital role in repairing DNA damage; however, polymorphisms in BER genes may influence an individual's susceptibility to disease risk. We investigated the role of BER genes as a biomarker of susceptibility among agricultural workers in Haryana, India.</p><p><strong>Methods: </strong>The pesticide-exposed workers (110) and unexposed controls (114) were genotyped for XRCC1 C26304T (rs1799782), XRCC1 G28152A (rs25487), APE1 T2197G (rs1130409), and OGG1 C1245G (rs1052133) using the PCR-RFLP technique. The allelic frequencies were compared using chi-square tests, with a significance level set at <i>p</i> < 0.05.</p><p><strong>Results: </strong>Significant results were observed for XRCC1: rs1799782 (T allele: 0.1409 vs. 0.0658; OR: 2.32; CI: 1.08-4.99; p: 0.028) and rs25487 (A allele: 0.332 vs. 0.202; OR: 1.90; CI: 1.29-2.80; p: 0.001) between exposed and control groups. The frequency of the APE1 Glu allele was significantly lower in exposed individuals (OR: 0.49; CI: 0.31-0.78; <i>p</i> = 0.003). In contrast, the OGG1 Cys allele was more frequent in the exposed group; however, the difference was not statistically significant (OR: 1.43; CI: 0.91-2.23; <i>p</i> = 0.113).</p><p><strong>Conclusion: </strong>Our findings suggest that DNA repair gene polymorphism may influence an individual's susceptibility to pesticide exposure, leading to oxidative damage and genotoxic effects.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"541-549"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145548048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-11-28DOI: 10.1080/1354750X.2025.2589251
Ke Wang, Qiong Chen, JinBing Deng, Xin Chen
Background: Several studies have identified that HOTAIR polymorphisms were expressed abnormally in a range of cancers, including breast, gastric, liver, and lung cancers. However, the impact of this gene on colorectal cancer (CRC) remains a topic of debate. To obtain the most accurate results, the association of HOTAIR polymorphisms with CRC risk was analyzed in this meta-analysis (MA).
Methods: The PubMed, Embase, Cochrane, and Web of Science databases were searched to find the correlation of HOTAIR polymorphisms with CRC up to February 2024. The association of HOTAIR polymorphisms with CRC susceptibility was assessed using odds ratios (ORs) and 95% confidence intervals (CIs).
Results: Five relevant studies were identified in total. In all HOTAIR polymorphism studies involving CRC, it was found that the subgroup analysis by ethnicity revealed that the rs1899663 G > T codominant and dominant models were positively correlated with CRC development in Asian populations and negatively correlated with CRC development in non-Asian populations (Codominant: OR = 0.70, 95% CI = 0.39-1.25; D: Dominant: OR = 0.65, 95% CI = 0.28-1.53).
Conclusions: This MA indicates that HOTAIR polymorphism-the rs1899663 G > T genotype-might have a racially specific impact on CRC risk.
背景:一些研究已经发现HOTAIR多态性在一系列癌症中异常表达,包括乳腺癌、胃癌、肝癌和肺癌。然而,该基因对结直肠癌(CRC)的影响仍然是一个有争议的话题。为了获得最准确的结果,本meta分析(MA)分析了HOTAIR多态性与结直肠癌风险的关系。方法:检索截至2024年2月的PubMed、Embase、Cochrane和Web of Science数据库,查找HOTAIR多态性与CRC的相关性。使用比值比(ORs)和95%置信区间(CIs)评估HOTAIR多态性与结直肠癌易感性的关系。结果:共纳入5项相关研究。在所有涉及CRC的HOTAIR多态性研究中,发现按种族进行亚组分析显示rs1899663 G > T共显性和显性模型与亚洲人群CRC发展呈正相关,与非亚洲人群CRC发展呈负相关(共显性:OR = 0.70, 95% CI = 0.39 - 1.25; D:显性:OR = 0.65, 95% CI = 0.28 - 1.53)。结论:该MA表明HOTAIR多态性- rs1899663 G b> T基因型-可能对结直肠癌风险具有种族特异性影响。
{"title":"Association of long non-coding RNA HOTAIR polymorphisms with colorectal cancer: a meta-analysis.","authors":"Ke Wang, Qiong Chen, JinBing Deng, Xin Chen","doi":"10.1080/1354750X.2025.2589251","DOIUrl":"10.1080/1354750X.2025.2589251","url":null,"abstract":"<p><strong>Background: </strong>Several studies have identified that HOTAIR polymorphisms were expressed abnormally in a range of cancers, including breast, gastric, liver, and lung cancers. However, the impact of this gene on colorectal cancer (CRC) remains a topic of debate. To obtain the most accurate results, the association of HOTAIR polymorphisms with CRC risk was analyzed in this meta-analysis (MA).</p><p><strong>Methods: </strong>The PubMed, Embase, Cochrane, and Web of Science databases were searched to find the correlation of HOTAIR polymorphisms with CRC up to February 2024. The association of HOTAIR polymorphisms with CRC susceptibility was assessed using odds ratios (ORs) and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Five relevant studies were identified in total. In all HOTAIR polymorphism studies involving CRC, it was found that the subgroup analysis by ethnicity revealed that the rs1899663 G > T codominant and dominant models were positively correlated with CRC development in Asian populations and negatively correlated with CRC development in non-Asian populations (Codominant: OR = 0.70, 95% CI = 0.39-1.25; D: Dominant: OR = 0.65, 95% CI = 0.28-1.53).</p><p><strong>Conclusions: </strong>This MA indicates that HOTAIR polymorphism-the rs1899663 G > T genotype-might have a racially specific impact on CRC risk.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"560-569"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145501730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-12-25DOI: 10.1080/1354750X.2025.2579636
Gabriella Bottari, Francesco Rosati, Danilo Fegatelli Alunni, Emanuel Paionni, Federica Ferrigno, Lorenza Romani, Maia De Luca, Laura Lancella, Ottavia Porzio, Paola Bernaschi, Anna Rita Vestri, Marta Ciofi Degli Atti, Massimiliano Raponi, Carlo Federico Perno, Corrado Cecchetti
Background: Pancreatic Stone Protein (PSP) has been proposed as a sepsis biomarker, but its role in severity stratification in pediatric intensive care and its relation to infectious source have not been explored.
Methods: We conducted a retrospective analysis of 97 pediatric patients admitted to the PICU with new-onset sepsis (within 24h from diagnosis). Blood samples were collected within 24h to measure PSP levels and compared with microbiological culture results.
Results: Among 97 patients, PSP levels were significantly higher in those with positive blood cultures (n = 24; median 108 ng/mL) compared with negatives (n = 73; 82 ng/mL, p = 0.008). When combining blood molecular testing with cultures, PSP remained higher in positives (n = 31; 111 ng/mL) than negatives (n = 66; 85 ng/mL, p = 0.026). PSP levels also correlated with sepsis severity: Non-septic (n = 55, median 72 ng/mL), sepsis (n = 22, median 238 ng/mL), septic shock (n = 20, 375 ng/mL) (p = 0.001). Receiver operating characteristic (ROC) curve analysis showed that PSP had superior accuracy in predicting sepsis severity (AUC 0.75, 95% CI 0.64-0.87) compared with C-reactive protein (C-RP, AUC 0.54, 95% 0.37-0.64) and procalcitonin (PCT, AUC 0.60, 95% CI 0.35-0.67).
Conclusions: PSP is a promising biomarker for sepsis detection and severity prediction in critically ill pediatric patients. Further studies are required to validate its integration into diagnostic protocols.
{"title":"Pancreatic Stone Protein levels reflect sepsis severity and bloodstream infections in critically ill children: a retrospective cohort analysis.","authors":"Gabriella Bottari, Francesco Rosati, Danilo Fegatelli Alunni, Emanuel Paionni, Federica Ferrigno, Lorenza Romani, Maia De Luca, Laura Lancella, Ottavia Porzio, Paola Bernaschi, Anna Rita Vestri, Marta Ciofi Degli Atti, Massimiliano Raponi, Carlo Federico Perno, Corrado Cecchetti","doi":"10.1080/1354750X.2025.2579636","DOIUrl":"10.1080/1354750X.2025.2579636","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic Stone Protein (PSP) has been proposed as a sepsis biomarker, but its role in severity stratification in pediatric intensive care and its relation to infectious source have not been explored.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of 97 pediatric patients admitted to the PICU with new-onset sepsis (within 24h from diagnosis). Blood samples were collected within 24h to measure PSP levels and compared with microbiological culture results.</p><p><strong>Results: </strong>Among 97 patients, PSP levels were significantly higher in those with positive blood cultures (n = 24; median 108 ng/mL) compared with negatives (n = 73; 82 ng/mL, p = 0.008). When combining blood molecular testing with cultures, PSP remained higher in positives (n = 31; 111 ng/mL) than negatives (n = 66; 85 ng/mL, p = 0.026). PSP levels also correlated with sepsis severity: Non-septic (n = 55, median 72 ng/mL), sepsis (n = 22, median 238 ng/mL), septic shock (n = 20, 375 ng/mL) (p = 0.001). Receiver operating characteristic (ROC) curve analysis showed that PSP had superior accuracy in predicting sepsis severity (AUC 0.75, 95% CI 0.64-0.87) compared with C-reactive protein (C-RP, AUC 0.54, 95% 0.37-0.64) and procalcitonin (PCT, AUC 0.60, 95% CI 0.35-0.67).</p><p><strong>Conclusions: </strong>PSP is a promising biomarker for sepsis detection and severity prediction in critically ill pediatric patients. Further studies are required to validate its integration into diagnostic protocols.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"550-559"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145480736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This retrospective immunohistochemical study evaluated the expression of 4-hydroxy-nonenal (4-HNE), a marker of lipid peroxidation (LP), in oral squamous cell carcinoma (OSCC) and compared staining intensities across different histopathological grades.
Materials and methods: Archived formalin-fixed, paraffin-embedded (FFPE) tissue blocks from 55 primary OSCC patients were analysed. Normal oral mucosa samples (n = 10) served as controls. Immuno-histochemical staining intensity for 4-HNE was semi-quantitatively assessed. Data were analysed using SPSS version 20.0 (SPSS Inc., Chicago, IL). The Chi-square test compared 4-HNE expression between normal and OSCC tissues, while the Kruskal-Wallis H test assessed differences among OSCC grades. A p-value <0.05 was considered statistically significant.
Results: In normal tissues, 90% showed no staining, and 10% exhibited mild staining (median score = 0). OSCC samples displayed moderate staining in 34.5% and intense staining in 65.5% (median score = 3). Among histological grades, well-differentiated (WD) tumours showed 40% moderate and 60% intense staining; moderately differentiated (MD), 30% moderate and 70% intense; poorly differentiated (PD), 33.3% moderate and 66.7% intense staining. Expression of 4-HNE was significantly higher in OSCC compared to controls (p < 0.001) but did not differ significantly among OSCC grades.
Conclusion: Elevated 4-HNE levels in OSCC suggest enhanced oxidative stress (OS) and LP, supporting its potential as a biomarker in carcinogenesis.
{"title":"Evaluation of the immunohistochemical expression of lipid peroxidation marker 4-HNE and comparison of the expression in various histopathological grades of oral squamous cell carcinoma.","authors":"Khadijah Mohideen, Chandrasekaran Krithika, Nadeem Jeddy, Pratibha Ramani, Sulaiman S Alqahtani, Saranya Ramsridhar","doi":"10.1080/1354750X.2025.2578004","DOIUrl":"10.1080/1354750X.2025.2578004","url":null,"abstract":"<p><strong>Objective: </strong>This retrospective immunohistochemical study evaluated the expression of 4-hydroxy-nonenal (4-HNE), a marker of lipid peroxidation (LP), in oral squamous cell carcinoma (OSCC) and compared staining intensities across different histopathological grades.</p><p><strong>Materials and methods: </strong>Archived formalin-fixed, paraffin-embedded (FFPE) tissue blocks from 55 primary OSCC patients were analysed. Normal oral mucosa samples (<i>n</i> = 10) served as controls. Immuno-histochemical staining intensity for 4-HNE was semi-quantitatively assessed. Data were analysed using SPSS version 20.0 (SPSS Inc., Chicago, IL). The Chi-square test compared 4-HNE expression between normal and OSCC tissues, while the Kruskal-Wallis H test assessed differences among OSCC grades. A <i>p</i>-value <0.05 was considered statistically significant.</p><p><strong>Results: </strong>In normal tissues, 90% showed no staining, and 10% exhibited mild staining (median score = 0). OSCC samples displayed moderate staining in 34.5% and intense staining in 65.5% (median score = 3). Among histological grades, well-differentiated (WD) tumours showed 40% moderate and 60% intense staining; moderately differentiated (MD), 30% moderate and 70% intense; poorly differentiated (PD), 33.3% moderate and 66.7% intense staining. Expression of 4-HNE was significantly higher in OSCC compared to controls (<i>p</i> < 0.001) but did not differ significantly among OSCC grades.</p><p><strong>Conclusion: </strong>Elevated 4-HNE levels in OSCC suggest enhanced oxidative stress (OS) and LP, supporting its potential as a biomarker in carcinogenesis.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"463-469"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145342855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Aflatoxin exposure studies in Kenya have focused mainly on risk-prone regions and food-based risk estimates, which may under- or overestimate internal dose.
Objective: This study estimated the chronic health risks associated with AFB1 exposure among smallholder farmers in Baringo County using urinary biomarker.
Methods: Urinary AFM1 (n = 72) was quantified using enzyme-linked immunosorbent assay and probable daily intake of AFB1 derived, incorporating participant-specific urine volumes and AFM1 excretion factors (1-2%). Deterministic and Monte Carlo modelling were used to assess risk.
Results: AFM1 was detected in 61.1% of urine samples (LOD: 0.10 ng/mL), indicating recent AFB1 exposure. The deterministic PDI range (86.236-260.976 ng/kg bw/day) yielded Margin of Exposure values (1.381-4.297), well below the European Food Safety Authority threshold (10,000), suggesting high public health concern. Monte Carlo simulation mean PDI was 149.349 ng/kg bw/day. Annual liver cancer risk exceeded the 1 case/100,000 person-years reference under national (HBV prevalence 3.0%; mean: 2.793; 95th percentile: 6.648) and county-level (HBV prevalence 11.9%; mean: 3.885; 95th percentile: 9.248) estimates.
Conclusions: These results indicate ongoing aflatoxin exposure and elevated health risk among the smallholder farmers in Baringo County. There is an urgent need for targeted dietary, storage and community education interventions and biomarker-integrated surveillance.
{"title":"Biomarker-based assessment of aflatoxin B<sub>1</sub> exposure and health risk among smallholder farmers in Baringo County, Kenya, using deterministic and probabilistic modelling.","authors":"Loureen Akinyi Awuor, Wilkister Nyaora Moturi, Meshack Amos Obonyo","doi":"10.1080/1354750X.2025.2589905","DOIUrl":"10.1080/1354750X.2025.2589905","url":null,"abstract":"<p><p><b>Background:</b> Aflatoxin exposure studies in Kenya have focused mainly on risk-prone regions and food-based risk estimates, which may under- or overestimate internal dose.</p><p><p><b>Objective:</b> This study estimated the chronic health risks associated with AFB<sub>1</sub> exposure among smallholder farmers in Baringo County using urinary biomarker.</p><p><p><b>Methods:</b> Urinary AFM<sub>1</sub> (<i>n</i> = 72) was quantified using enzyme-linked immunosorbent assay and probable daily intake of AFB<sub>1</sub> derived, incorporating participant-specific urine volumes and AFM<sub>1</sub> excretion factors (1-2%). Deterministic and Monte Carlo modelling were used to assess risk.</p><p><p><b>Results:</b> AFM<sub>1</sub> was detected in 61.1% of urine samples (LOD: 0.10 ng/mL), indicating recent AFB<sub>1</sub> exposure. The deterministic PDI range (86.236-260.976 ng/kg bw/day) yielded Margin of Exposure values (1.381-4.297), well below the European Food Safety Authority threshold (10,000), suggesting high public health concern. Monte Carlo simulation mean PDI was 149.349 ng/kg bw/day. Annual liver cancer risk exceeded the 1 case/100,000 person-years reference under national (HBV prevalence 3.0%; mean: 2.793; 95th percentile: 6.648) and county-level (HBV prevalence 11.9%; mean: 3.885; 95th percentile: 9.248) estimates.</p><p><p><b>Conclusions:</b> These results indicate ongoing aflatoxin exposure and elevated health risk among the smallholder farmers in Baringo County. There is an urgent need for targeted dietary, storage and community education interventions and biomarker-integrated surveillance.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"477-485"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145522752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breast cancer remains a leading cause of cancer-related mortality among women worldwide, emphasizing the urgent need for improved diagnostic and therapeutic strategies. This review comprehensively explores the emerging landscape of breast cancer biomarkers, integrating insights from molecular mechanisms, clinical validation, and future translational applications. It highlights the evolution from classical receptor-based classification (ER, PR, HER2) to next-generation multi omics and AI-assisted biomarker discovery. Particular emphasis is placed on genetic, epigenetic, proteomic, and metabolomic markers, as well as liquid biopsy derived components such as ctDNA methylation, exosomal RNA, and extracellular vesicle biomarkers. The review critically analyses the reliability, reproducibility, and regulatory challenges of biomarker validation in clinical trials, including assay standardization and patient heterogeneity. Additionally, the discussion underscores the growing role of artificial intelligence in computational pathology and data harmonization across omics platforms. Limitations of current approaches and future research directions such as integrative modelling, personalized diagnostics, and real-world clinical translation are outlined to guide ongoing advancements in precision oncology. Overall, this article provides a mechanistic, evidence-based, and forward-looking overview of how emerging biomarkers are reshaping breast cancer diagnosis, prognosis, and therapeutic decision-making.
{"title":"Emerging biomarkers in breast cancer: translational and multi-omics perspectives in precision oncology.","authors":"Azra Yasmin, Ritesh Jha, Aarti Passi, Purabi Saha, Jugnu Goyal, Shammy Jindal, Kamya Goyal","doi":"10.1080/1354750X.2025.2591717","DOIUrl":"10.1080/1354750X.2025.2591717","url":null,"abstract":"<p><p>Breast cancer remains a leading cause of cancer-related mortality among women worldwide, emphasizing the urgent need for improved diagnostic and therapeutic strategies. This review comprehensively explores the emerging landscape of breast cancer biomarkers, integrating insights from molecular mechanisms, clinical validation, and future translational applications. It highlights the evolution from classical receptor-based classification (ER, PR, HER2) to next-generation multi omics and AI-assisted biomarker discovery. Particular emphasis is placed on genetic, epigenetic, proteomic, and metabolomic markers, as well as liquid biopsy derived components such as ctDNA methylation, exosomal RNA, and extracellular vesicle biomarkers. The review critically analyses the reliability, reproducibility, and regulatory challenges of biomarker validation in clinical trials, including assay standardization and patient heterogeneity. Additionally, the discussion underscores the growing role of artificial intelligence in computational pathology and data harmonization across omics platforms. Limitations of current approaches and future research directions such as integrative modelling, personalized diagnostics, and real-world clinical translation are outlined to guide ongoing advancements in precision oncology. Overall, this article provides a mechanistic, evidence-based, and forward-looking overview of how emerging biomarkers are reshaping breast cancer diagnosis, prognosis, and therapeutic decision-making.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"516-540"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145548098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Chronic kidney disease (CKD) typically shows no symptoms in its initial stages. A quick diagnosis (stages 1-3) can change the course of CKD and lessen its effects. Significant kidney damage becomes apparent during stages 4 and 5, which typically leads to end-stage renal failure. Although blood urea and serum creatinine (sCr) values are mainly used to diagnose CKD, sCr has shown low predictive ability.
Methods: We searched Pubmed, google scholar, and various databases to see the role of various biomarkers in CKD. The advent of new methods will enable the discovery of new biomarkers in renal disorders due to advancements in transcriptomics, genomes, epigenetics, proteomics, and metabolomics.
Results: Neutrophil gelatinase-associated lipocalin (NGAL), Galectin-3, kidney injury molecule-1 (KIM-1), Interleukin 18 (IL-18), Immunoglobulin G, Liver Fatty Acid-Binding Protein (L-FABP), asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), miRNA biomarker, uromodulin, Nephrin, epidermal growth factor (EGF), proteomic and metabolomic biomarkers, as well as podocalyxin are few novel potential biomarkers for CKD detection as well as forecasting outcomes presented in this review.
Conclusion: It appears that novel markers could replace traditional ones in future and evaluation of their effectiveness, sensitivity, specificity etc. are also necessary.
{"title":"A comprehensive review of new potential biomarkers in the detection of chronic kidney disease.","authors":"Sapna, Pankaj Kumar, Bipul Kalita, Suresh Babu Kondaveeti, Vivek Kumar Garg, Asmi, Vaishali Aggarwal","doi":"10.1080/1354750X.2025.2586589","DOIUrl":"10.1080/1354750X.2025.2586589","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic kidney disease (CKD) typically shows no symptoms in its initial stages. A quick diagnosis (stages 1-3) can change the course of CKD and lessen its effects. Significant kidney damage becomes apparent during stages 4 and 5, which typically leads to end-stage renal failure. Although blood urea and serum creatinine (sCr) values are mainly used to diagnose CKD, sCr has shown low predictive ability.</p><p><strong>Methods: </strong>We searched Pubmed, google scholar, and various databases to see the role of various biomarkers in CKD. The advent of new methods will enable the discovery of new biomarkers in renal disorders due to advancements in transcriptomics, genomes, epigenetics, proteomics, and metabolomics.</p><p><strong>Results: </strong>Neutrophil gelatinase-associated lipocalin (NGAL), Galectin-3, kidney injury molecule-1 (KIM-1), Interleukin 18 (IL-18), Immunoglobulin G, Liver Fatty Acid-Binding Protein (L-FABP), asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), miRNA biomarker, uromodulin, Nephrin, epidermal growth factor (EGF), proteomic and metabolomic biomarkers, as well as podocalyxin are few novel potential biomarkers for CKD detection as well as forecasting outcomes presented in this review.</p><p><strong>Conclusion: </strong>It appears that novel markers could replace traditional ones in future and evaluation of their effectiveness, sensitivity, specificity etc. are also necessary.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"503-515"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145538304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-11-27DOI: 10.1080/1354750X.2025.2591716
Muhammad Waseem Aslam, Ali Umar, Muhammad Saleem Khan, Muhammad Wajid, Sabeen Sabri, Misbah Ullah Khan
Objectives: The current study explores the synthesis, characterization and toxicity of copper oxides (CuO-NPs) in albino mice.
Methods: NPs were synthesized and albino mice were exposed to these nps orally for 30 days.
Results: The nanoparticles exhibited a porous, rough-surfaced, spherical morphology; XRD confirmed their crystallinity, while FTIR revealed key functional groups. H1 (5 mg/kg) and H2 (15 mg/kg) of CuO-NPs exposure induced significant alterations in haematological parameters, including elevated WBCs counts, platelets and a significant decrease in haemoglobin and platelets distribution width. Biochemical analyses revealed changes in lipid profile, kidney, and liver biomarkers, indicating potential toxicity. Histological studies of the liver indicated sinusoidal lumen, necrosis, opening of the central vein, lymphocytic infiltration, irregular nucleus, degeneration of hepatocytes, and antinucleosis. In the kidney, glomerular destruction, necrosis, tubular degeneration, vascular degeneration, anisokaryosis, and expansion of the central vein were recorded. The heart tissues showed congestion, fatty degeneration, infiltration of inflammatory cells, and necrosis in the treated group. Molecular interactions revealed CuO NPs interacted with albumin, AST, bilirubin, and fibrinogen showing potential toxicity.
Conclusion: This study highlights the link between nanomaterial properties, physiological changes, and molecular interactions underlying CuO NP toxicity, emphasizing the need for further research on their safe use and biomedical applications.
{"title":"Sub-chronic toxicity of chemically synthesized CuO-NPs in albino mice.","authors":"Muhammad Waseem Aslam, Ali Umar, Muhammad Saleem Khan, Muhammad Wajid, Sabeen Sabri, Misbah Ullah Khan","doi":"10.1080/1354750X.2025.2591716","DOIUrl":"10.1080/1354750X.2025.2591716","url":null,"abstract":"<p><p><b>Objectives:</b> The current study explores the synthesis, characterization and toxicity of copper oxides (CuO-NPs) in albino mice.</p><p><p><b>Methods:</b> NPs were synthesized and albino mice were exposed to these nps orally for 30 days.</p><p><p><b>Results:</b> The nanoparticles exhibited a porous, rough-surfaced, spherical morphology; XRD confirmed their crystallinity, while FTIR revealed key functional groups. H1 (5 mg/kg) and H2 (15 mg/kg) of CuO-NPs exposure induced significant alterations in haematological parameters, including elevated WBCs counts, platelets and a significant decrease in haemoglobin and platelets distribution width. Biochemical analyses revealed changes in lipid profile, kidney, and liver biomarkers, indicating potential toxicity. Histological studies of the liver indicated sinusoidal lumen, necrosis, opening of the central vein, lymphocytic infiltration, irregular nucleus, degeneration of hepatocytes, and antinucleosis. In the kidney, glomerular destruction, necrosis, tubular degeneration, vascular degeneration, anisokaryosis, and expansion of the central vein were recorded. The heart tissues showed congestion, fatty degeneration, infiltration of inflammatory cells, and necrosis in the treated group. Molecular interactions revealed CuO NPs interacted with albumin, AST, bilirubin, and fibrinogen showing potential toxicity.</p><p><p><b>Conclusion:</b> This study highlights the link between nanomaterial properties, physiological changes, and molecular interactions underlying CuO NP toxicity, emphasizing the need for further research on their safe use and biomedical applications.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"486-502"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145548053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: The aim of this study is to see the association of P-selectin, E-selectin, Vascular Cell Adhesion Molecule-1 (VCAM-1) and Intercellular Adhesion Molecule-1 (ICAM-1) with Vaso-occlusive crisis (VOC) in sickle cell disease patients.
Methods: In this longitudinal study, a total of 140 SCD patients admitted into a Government Medical College, Jabalpur, were recruited. Plasma levels of soluble P-selectin, E-Selectin, ICAM-1, and VCAM-1 were measured at three different time points, that is, (i) at the time of admission (n = 140), (ii) at discharge (n = 139), and (iii) during steady state (n = 118).
Results: The most common presenting symptoms at the time of VOC were severe joint pain (65.7%) and back pain (49.3%). All the cell adhesion molecule levels were similar in males and females except sVCAM-1. The plasma P-selectin, E-Selectin, ICAM-1 and VCAM-1 levels were significantly higher during crisis than at the discharge and steady state. No statistically significant association of any of the CAM levels with the severity of pain was observed. High plasma VCAM-1 levels (≥1676 ng/mL) were associated with longer duration of hospital stay.
Conclusions: Significant association of soluble CAMs with VOC in SCD suggests that soluble CAMs play a crucial role in the pathophysiology of the VOC.
{"title":"Association of cell adhesion molecules with Vaso-occlusive crisis in sickle cell disease.","authors":"Parul Gupta, Brajesh Patel, Asha Tiwari, Pankaj Asati, Ravindra Kumar","doi":"10.1080/1354750X.2025.2586746","DOIUrl":"10.1080/1354750X.2025.2586746","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to see the association of P-selectin, E-selectin, Vascular Cell Adhesion Molecule-1 (VCAM-1) and Intercellular Adhesion Molecule-1 (ICAM-1) with Vaso-occlusive crisis (VOC) in sickle cell disease patients.</p><p><strong>Methods: </strong>In this longitudinal study, a total of 140 SCD patients admitted into a Government Medical College, Jabalpur, were recruited. Plasma levels of soluble P-selectin, E-Selectin, ICAM-1, and VCAM-1 were measured at three different time points, that is, (i) at the time of admission (n = 140), (ii) at discharge (n = 139), and (iii) during steady state (n = 118).</p><p><strong>Results: </strong>The most common presenting symptoms at the time of VOC were severe joint pain (65.7%) and back pain (49.3%). All the cell adhesion molecule levels were similar in males and females except sVCAM-1. The plasma P-selectin, E-Selectin, ICAM-1 and VCAM-1 levels were significantly higher during crisis than at the discharge and steady state. No statistically significant association of any of the CAM levels with the severity of pain was observed. High plasma VCAM-1 levels (≥1676 ng/mL) were associated with longer duration of hospital stay.</p><p><strong>Conclusions: </strong>Significant association of soluble CAMs with VOC in SCD suggests that soluble CAMs play a crucial role in the pathophysiology of the VOC.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"470-476"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145480761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}